Merck & Co – known as MSD outside of the US and Canada – has shared positive results from a late-stage trial of a Keytruda ...

Eli Lilly has announced a $3bn expansion to the US manufacturing facility that it acquired from Nexus Pharmaceuticals earlier ...

GSK and Duality Biologics have entered into an exclusive option agreement worth over $1bn for DualityBio’s preclinical ...

Merck & Co – known as MSD outside of the US and Canada – and Ridgeback Biotherapeutics have initiated a late-stage study to ...

Sanofi has presented promising results from a phase 3 study of its investigational oral Bruton’s tyrosine kinase (BTK) ...

GSK and Rgenta Therapeutics have partnered to develop RNA-targeting small molecule splice modulators for disease areas ...

Managing data effectively can be challenging in any industry. But it’s especially difficult in pharmaceuticals, which faces ...

Of the patients in the poze-cemdi group, 93% achieved LDH normalisation across study visits on average, compared to 65% of ...

Did you know we offer a suite of education and training options? Our workshops, insight sessions, and training help Pharma ...

Johnson & Johnson (J&J) has shared positive data from a late-stage study of its subcutaneous CD38-directed antibody Darzalex ...

From animation and gamification, to events, influencers, opinion leaders, and chatbots; there are tools and tactics which can ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.